These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27812199)

  • 1. Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells.
    Speidel A; Felk S; Reinhardt P; Sterneckert J; Gillardon F
    PLoS One; 2016; 11(11):e0165949. PubMed ID: 27812199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.
    López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R
    J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
    Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
    Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain.
    Xu E; Boddu R; Abdelmotilib HA; Sokratian A; Kelly K; Liu Z; Bryant N; Chandra S; Carlisle SM; Lefkowitz EJ; Harms AS; Benveniste EN; Yacoubian TA; Volpicelli-Daley LA; Standaert DG; West AB
    Mol Neurodegener; 2022 Jan; 17(1):7. PubMed ID: 35012605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 Is Recruited to Phagosomes and Co-recruits RAB8 and RAB10 in Human Pluripotent Stem Cell-Derived Macrophages.
    Lee H; Flynn R; Sharma I; Haberman E; Carling PJ; Nicholls FJ; Stegmann M; Vowles J; Haenseler W; Wade-Martins R; James WS; Cowley SA
    Stem Cell Reports; 2020 May; 14(5):940-955. PubMed ID: 32359446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.
    Ohta E; Nihira T; Uchino A; Imaizumi Y; Okada Y; Akamatsu W; Takahashi K; Hayakawa H; Nagai M; Ohyama M; Ryo M; Ogino M; Murayama S; Takashima A; Nishiyama K; Mizuno Y; Mochizuki H; Obata F; Okano H
    Hum Mol Genet; 2015 Sep; 24(17):4879-900. PubMed ID: 26056228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
    Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.
    Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH
    Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
    Schwab AJ; Sison SL; Meade MR; Broniowska KA; Corbett JA; Ebert AD
    Stem Cell Reports; 2017 Dec; 9(6):1839-1852. PubMed ID: 29129681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.
    Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of gene-corrected iPSC line, KIOMi002-A, from Parkinson's disease patient iPSC with LRRK2 G2019S mutation using BAC-based homologous recombination.
    Lee SY; Chung SK
    Stem Cell Res; 2019 Dec; 41():101649. PubMed ID: 31731184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects.
    Borgs L; Peyre E; Alix P; Hanon K; Grobarczyk B; Godin JD; Purnelle A; Krusy N; Maquet P; Lefebvre P; Seutin V; Malgrange B; Nguyen L
    Sci Rep; 2016 Sep; 6():33377. PubMed ID: 27640816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression.
    Zhu Y; Wang C; Yu M; Cui J; Liu L; Xu Z
    Protein Cell; 2013 Sep; 4(9):711-21. PubMed ID: 27023913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
    Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R
    Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes.
    Booth HDE; Wessely F; Connor-Robson N; Rinaldi F; Vowles J; Browne C; Evetts SG; Hu MT; Cowley SA; Webber C; Wade-Martins R
    Neurobiol Dis; 2019 Sep; 129():56-66. PubMed ID: 31085228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14
    Ikezu T; Koro L; Wolozin B; Farraye FA; Strongosky AJ; Wszolek ZK
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):794-800. PubMed ID: 32180132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurite Collapse and Altered ER Ca
    Korecka JA; Talbot S; Osborn TM; de Leeuw SM; Levy SA; Ferrari EJ; Moskites A; Atkinson E; Jodelka FM; Hinrich AJ; Hastings ML; Woolf CJ; Hallett PJ; Isacson O
    Stem Cell Reports; 2019 Jan; 12(1):29-41. PubMed ID: 30595548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells.
    Panagiotakopoulou V; Ivanyuk D; De Cicco S; Haq W; Arsić A; Yu C; Messelodi D; Oldrati M; Schöndorf DC; Perez MJ; Cassatella RP; Jakobi M; Schneiderhan-Marra N; Gasser T; Nikić-Spiegel I; Deleidi M
    Nat Commun; 2020 Oct; 11(1):5163. PubMed ID: 33057020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.